These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 33782648)

  • 1. Preventing and Treating Neurological Disorders with the Flavonol Fisetin.
    Maher P
    Brain Plast; 2021 Feb; 6(2):155-166. PubMed ID: 33782648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fisetin, potential flavonoid with multifarious targets for treating neurological disorders: An updated review.
    Ravula AR; Teegala SB; Kalakotla S; Pasangulapati JP; Perumal V; Boyina HK
    Eur J Pharmacol; 2021 Nov; 910():174492. PubMed ID: 34516952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How fisetin reduces the impact of age and disease on CNS function.
    Maher P
    Front Biosci (Schol Ed); 2015 Jun; 7(1):58-82. PubMed ID: 25961687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the Neuroprotective and Anti-inflammatory Activities of the Flavonol Fisetin by the Transition Metals Iron and Copper.
    Maher P
    Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33187316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragment-based drug discovery and biological evaluation of novel cannabinol-based inhibitors of oxytosis/ferroptosis for neurological disorders.
    Liang Z; Candib A; Soriano-Castell D; Fischer W; Finley K; Maher P
    Redox Biol; 2024 Jun; 72():103138. PubMed ID: 38581858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ferroptosis pathways in neuroinflammation and neurological disorders: From pathogenesis to treatment.
    Mohan S; Alhazmi HA; Hassani R; Khuwaja G; Maheshkumar VP; Aldahish A; Chidambaram K
    Heliyon; 2024 Feb; 10(3):e24786. PubMed ID: 38314277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection.
    Elsallabi O; Patruno A; Pesce M; Cataldi A; Carradori S; Gallorini M
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of fisetin and other berry flavonoids in Parkinson's disease.
    Maher P
    Food Funct; 2017 Sep; 8(9):3033-3042. PubMed ID: 28714503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the Oxytosis/Ferroptosis Pathway to Understand and Treat Age-Associated Neurodegenerative Diseases.
    Maher P; Currais A; Schubert D
    Cell Chem Biol; 2020 Dec; 27(12):1456-1471. PubMed ID: 33176157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders.
    Li J; Jia B; Cheng Y; Song Y; Li Q; Luo C
    Oxid Med Cell Longev; 2022; 2022():3999083. PubMed ID: 35910843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fisetin's Promising Antitumor Effects: Uncovering Mechanisms and Targeting for Future Therapies.
    Qaed E; Al-Hamyari B; Al-Maamari A; Qaid A; Alademy H; Almoiliqy M; Munyemana JC; Al-Nusaif M; Alafifi J; Alyafeai E; Safi M; Geng Z; Tang Z; Ma X
    Glob Med Genet; 2023 Sep; 10(3):205-220. PubMed ID: 37565061
    [No Abstract]   [Full Text] [Related]  

  • 12. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
    Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
    In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Neuroprotective Flavonoids Sterubin and Fisetin Maintain Mitochondrial Health under Oxytotic/Ferroptotic Stress and Improve Bioenergetic Efficiency in HT22 Neuronal Cells.
    Goujon M; Liang Z; Soriano-Castell D; Currais A; Maher P
    Antioxidants (Basel); 2024 Apr; 13(4):. PubMed ID: 38671908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell therapy for neurological disorders: A focus on aging.
    Nguyen H; Zarriello S; Coats A; Nelson C; Kingsbury C; Gorsky A; Rajani M; Neal EG; Borlongan CV
    Neurobiol Dis; 2019 Jun; 126():85-104. PubMed ID: 30219376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling.
    Wu Y; Chen M; Jiang J
    Mitochondrion; 2019 Nov; 49():35-45. PubMed ID: 31288090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
    Maher P
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NADPH oxidase in brain injury and neurodegenerative disorders.
    Ma MW; Wang J; Zhang Q; Wang R; Dhandapani KM; Vadlamudi RK; Brann DW
    Mol Neurodegener; 2017 Jan; 12(1):7. PubMed ID: 28095923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases.
    Sun Y; Xia X; Basnet D; Zheng JC; Huang J; Liu J
    Front Aging Neurosci; 2022; 14():904152. PubMed ID: 35837484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising use of metformin in treating neurological disorders: biomarker-guided therapies.
    Loan A; Syal C; Lui M; He L; Wang J
    Neural Regen Res; 2024 May; 19(5):1045-1055. PubMed ID: 37862207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.